APASL: a new era begins
It was my first visit to Brisbane. The walk from my hotel to the conference took in lush botanical gardens then a stroll through the vibrant cultural quarter on the city’s south bank, looking across to a booming CBD. Brisbane felt like an interesting place to be, both inside the Convention Centre and out.
Hepatitis C was front and centre at APASL 2014, the region’s largest liver disease conference with over 3,000 attendees. The miracle of an interferon-free treatment is now tantalisingly close, with a slew of direct-acting antivirals likely to get approval in the next couple of years.
But clinicians and